5 Hrs
Source:
الصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
5 Hrsالصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
5 HrsReady to play
Ready to play
Reports indicate that a new treatment for type 2 diabetes, known as "Eplisitor Alpha," is an effective alternative to daily injections, potentially reducing the number of injections by up to 86%, from 365 to just 52 per year. The therapy is administered once a week and is believed to enable patients—especially seniors and those with limited mobility—to enjoy a more flexible life, along with improved blood sugar management and a reduction in health complications. With approval from the National Institute for Health and Care Excellence (NICE) in the UK, the regulatory agency (MHRA) has not yet officially approved this treatment.
Notice: This Is an AI-Generated Summary
Comments (0)